BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

816 related articles for article (PubMed ID: 25597612)

  • 1. Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing.
    Song C; Chen H; Wang T; Zhang W; Ru G; Lang J
    Prostate; 2015 Apr; 75(5):500-16. PubMed ID: 25597612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep sequencing.
    Hart M; Nolte E; Wach S; Szczyrba J; Taubert H; Rau TT; Hartmann A; Grässer FA; Wullich B
    Mol Cancer Res; 2014 Feb; 12(2):250-63. PubMed ID: 24337069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
    Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
    Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the microRNA expression profile in the regenerative neonatal mouse heart by deep sequencing.
    Liu HL; Zhu JG; Liu YQ; Fan ZG; Zhu C; Qian LM
    Cell Biochem Biophys; 2014 Sep; 70(1):635-42. PubMed ID: 24756729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions.
    Meng Y; Quan L; Liu A
    Gene; 2018 Feb; 642():205-211. PubMed ID: 29128636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
    Li H; Xie S; Liu M; Chen Z; Liu X; Wang L; Li D; Zhou Y
    Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activin A regulates microRNAs and gene expression in LNCaP cells.
    Ottley EC; Nicholson HD; Gold EJ
    Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer.
    Guzel E; Karatas OF; Semercioz A; Ekici S; Aykan S; Yentur S; Creighton CJ; Ittmann M; Ozen M
    Int J Cancer; 2015 Feb; 136(4):875-9. PubMed ID: 24976077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidate diagnostic miRNAs that can detect cancer in prostate biopsy.
    Paziewska A; Mikula M; Dabrowska M; Kulecka M; Goryca K; Antoniewicz A; Dobruch J; Borowka A; Rutkowski P; Ostrowski J
    Prostate; 2018 Feb; 78(3):178-185. PubMed ID: 29226351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate Cancer.
    Daniel R; Wu Q; Williams V; Clark G; Guruli G; Zehner Z
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer.
    Tsuchiyama K; Ito H; Taga M; Naganuma S; Oshinoya Y; Nagano K; Yokoyama O; Itoh H
    Prostate; 2013 Jun; 73(8):827-34. PubMed ID: 23184537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
    Fuse M; Kojima S; Enokida H; Chiyomaru T; Yoshino H; Nohata N; Kinoshita T; Sakamoto S; Naya Y; Nakagawa M; Ichikawa T; Seki N
    J Hum Genet; 2012 Nov; 57(11):691-9. PubMed ID: 22854542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next generation sequencing reveals microRNA isoforms in liver cirrhosis and hepatocellular carcinoma.
    Wojcicka A; Swierniak M; Kornasiewicz O; Gierlikowski W; Maciag M; Kolanowska M; Kotlarek M; Gornicka B; Koperski L; Niewinski G; Krawczyk M; Jazdzewski K
    Int J Biochem Cell Biol; 2014 Aug; 53():208-17. PubMed ID: 24875649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA expression profiling of Chinese follicular lymphoma by microarray: A preliminary study.
    Pan Y; Guo Y; Luo Y; Li H; Xu Y
    Int Immunopharmacol; 2016 Oct; 39():41-47. PubMed ID: 27409728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA.
    Fu M; Gao Y; Zhou Q; Zhang Q; Peng Y; Tian K; Wang J; Zheng X
    Gene; 2014 Feb; 536(2):272-8. PubMed ID: 24361963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profile of microRNAs in gastrointestinal stromal tumors revealed by high throughput quantitative RT-PCR microarray.
    Tong HX; Zhou YH; Hou YY; Zhang Y; Huang Y; Xie B; Wang JY; Jiang Q; He JY; Shao YB; Han WM; Tan RY; Zhu J; Lu WQ
    World J Gastroenterol; 2015 May; 21(19):5843-55. PubMed ID: 26019448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.
    Pashaei E; Pashaei E; Ahmady M; Ozen M; Aydin N
    PLoS One; 2017; 12(6):e0179543. PubMed ID: 28651018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of miRNAs in enterovirus 71-infected cells.
    Xun M; Ma CF; Du QL; Ji YH; Xu JR
    Virol J; 2015 Apr; 12():56. PubMed ID: 25889836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
    Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.